API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2023/04/17/2648395/0/en/SpringWorks-and-BeiGene-Present-Clinical-Data-on-Lifirafenib-in-combination-with-Mirdametinib-in-Patients-with-Advanced-or-Refractory-Solid-Tumors-with-MAPK-Pathway-Aberrations-at-.html
https://www.businesswire.com/news/home/20190506005105/en/SpringWorks-Therapeutics-Announces-Initiation-Phase-1b-Clinical/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.fiercebiotech.com/biotech/springworks-names-a-ceo-inks-a-combo-therapy-deal-beigene